Antibody Drug Conjugates Market Outlook: Investors Still Miss the Big Assessment - Immunomedics, Bayer HealthCare, Heidelberg Pharma
The report segments the market based on drugs, technology, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla. Based on mechanism of action, it is classified into CD30 antibodies and HER2 antibodies. Based on application, the antibody drug conjugates market is categorized into breast cancer, lymphoma, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
View full press release